Department: Quality Control / Quality Assurance / Quality-Investigation
Designation: Officer / Sr. Officer / Executive / Sr. Executive
Candidate should be B.Sc. / M.Sc./B.Pharm / B.E / B.Tech
Experience: 2 to 8 years of experience working with Pharma Industries.
Job Location: Tarapur, Maharashtra
Walk-In Date – 13th April 2023 (Saturday)
Venue – “Lupin Ltd, Tarapur”, | T-142 MIDC Industrial Area, Tarapur Via Boisar. | Tarapur – 401506
Time: 10.30 am to 3.00 pm
Important Note:
Highest degree must have 1st Class/60% marks or 05 years of experience if 2nd Class
For any queries kindly revert on 7391040115 or send your profiles on prachipatil@lupin.com
Please circulate this advertisement with your all contacts | related WhatsApp, Telegram, Linkedin Group etc.
Lupin's journey serves as a tribute to the creative potential, empathy, and undying desire for a better tomorrow in humankind. Since its founding in 1968 by the visionary Dr. Desh Bandhu Gupta, Lupin has grown from modest beginnings to become a pioneer in the world of healthcare. With our headquarters in Mumbai, India, we have grown throughout the United States, Latin America, Asia, and Europe. We now operate in more than 100 countries and provide a wide range of products, numbering in the thousands. Lupin is steadfast in its pursuit of its goal of ensuring that everyone has access to high-quality healthcare, drawing inspiration from the hardy lupin flower that thrives in harsh environments and nourishes the earth. We understand how critical it is to support the communities we work with and make a constructive contribution to society.
Lupin's extensive global manufacturing network enables us to provide our clients with products that are guaranteed to be of high quality. The objective of producing quality, reasonably priced medications that fulfill unmet patient requirements is shaped by our investments in manufacturing capital. We keep increasing automation and capacity to support our pipeline of sophisticated generics and biotechnology items in accordance with our growth strategy.
The high-potency product manufacturing block at Indore Unit I, the cutting-edge Metered Dose Inhalers (MDI) plant at Indore Unit III, the Pyrazinamide API block at the Visakhapatnam unit, the new, cutting-edge facility for Oral Solid Dose (OSD) formulations and injectables at the Nagpur SEZ unit, and the multiplication of our Biotech Drug Substance facility in Pune are just a few of the new areas we have recently created capacities in.